{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-084079","form_type":"8-K","ticker":null,"cik":"0001678848","company_name":"CAMBELL INTERNATIONAL HOLDING CORP.","filed_at":"2022-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.680117+00:00","generated_at":"2026-06-20T21:30:25.224282+00:00","sec_items":["1.01","2.01","3.02","5.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"medium","headline":"Bitmis completes reverse merger with Cambell International, shifts focus to β-carotene health products","bullets":["Reverse acquisition of Cambell International closed on Dec 30, 2022; Bitmis issued 1M common shares and transferred 9M Series A Preferred shares to Cambell shareholders.","Xiaoyan Yuan resigned as CEO/CFO/COO/director; Sun Xiuzhi appointed as CEO, CFO, and director effective immediately.","Post-merger, company will focus on natural β-carotene extraction and health food products via LiaoNing KangBaiEr Biotechnology Development Co., Ltd.","Bitmis trades on OTC Expert Market under ticker BIMT; no financial statements provided yet."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-084079","json":"https://secwatch.observer/filing/0001213900-22-084079.json","markdown":"https://secwatch.observer/filing/0001213900-22-084079.md","text":"https://secwatch.observer/filing/0001213900-22-084079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678848/000121390022084079/0001213900-22-084079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678848/000121390022084079/ea171076-8k_bitmiscorp.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:30:25.224282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9be635dbd55b3e29d3bc3dd809e484169bd332e","claim":"CAMBELL INTERNATIONAL HOLDING CORP. underwent a change of control involving Cambell International Holding Limited (closed 2022-12-30).","evidence_excerpt":"Pursuant to the Business Combination, a change of control of Bitmis Corp. occurred as of the Closing Date.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1678848/000121390022084079/0001213900-22-084079-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Cambell International Holding Limited"},{"label":"Closing","value":"2022-12-30"}],"fact_type":"ma_transaction"},{"claim_id":"ece9492d45671888f69027fb939ea4a557f1c35a","claim":"CAMBELL INTERNATIONAL HOLDING CORP. completed an acquisition involving Cambell International Holding Limited and its shareholders for aggregate of 1,000,000 shares of our common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stoc (closed 2022-12-30).","evidence_excerpt":"Shareholders”) to acquire all the issued and outstanding capital stock of Cambell International in exchange for the issuance to the Cambell Shareholders of an aggregate of 1,000,000 shares (the “Shares”) of our common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stock owned by her","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1678848/000121390022084079/0001213900-22-084079-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Cambell International Holding Limited and its shareholders"},{"label":"Consideration","value":"aggregate of 1,000,000 shares of our common stock and the transfer by Ms. Xiaoyan to the Cambell Shareholders of 9,000,000 shares of our Series A Preferred Stoc"},{"label":"Closing","value":"2022-12-30"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}